Showing results (211-220 of 1,091) with videos related to
Sort By:
Pageof 110
Idrugs : the Investigational Drugs Journal|December 4, 2008
Is QSAR relevant to drug discovery?Arthur M DoweykoIdrugs : the Investigational Drugs Journal|December 4, 2008
Prediction of CYP-mediated drug interactions in vivo using in vitro dataRobert S Foti, Jan L WahlstromIdrugs : the Investigational Drugs Journal|November 7, 2008
Ion channel targets - select biosciences' fourth annual conferenceMats Holmqvist, Merritt MadukeIdrugs : the Investigational Drugs Journal|November 7, 2008
From Genome to Proteome: Integration and proteome completion - 8th Siena MeetingAsa M Wheelock, Craig E WheelockIdrugs : the Investigational Drugs Journal|November 7, 2008
Genetic approaches for target identification in sleep/wake systemsChristopher J Winrow, Fred W Turek, John J RengerIdrugs : the Investigational Drugs Journal|November 7, 2008
High-content screening: a new primary screening tool?Marc BickleIdrugs : the Investigational Drugs Journal|November 7, 2008
ZT-031, a cyclized analog of parathyroid hormone(1-31) for the potential treatment of osteoporosisEdward F NemethIdrugs : the Investigational Drugs Journal|July 7, 2009
Trabedersen, a TGFbeta2-specific antisense oligonucleotide for the treatment of malignant gliomas and other tumors overexpressing TGFbeta2Luc VallièresIdrugs : the Investigational Drugs Journal|April 1, 2009
Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseasesMalini BajpaiIdrugs : the Investigational Drugs Journal|May 1, 2010
Pharmaceutical Pricing and Market Access Outlook Europe 2010-HealthNetwork Communications' fourth annual conference. 24-25 March 2010, London, UKErhimuvi OgbighelePageof 110